Genmab: prices ADS offering at 17.75 dollars per share
(CercleFinance.com) - Danish biotech firm Genmab on Thursday priced its initial public offering of American Depositary Shares (ADS) on the Nasdaq at 17.
75 dollars per share.
The listing will generate gross proceeds of 505 million dollars from the sale of 28.5 million ADS, Genmab said, with each ADS representing one-tenth of one ordinary share.
The ADSs started trading on the Nasdaq this morning.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
75 dollars per share.
The listing will generate gross proceeds of 505 million dollars from the sale of 28.5 million ADS, Genmab said, with each ADS representing one-tenth of one ordinary share.
The ADSs started trading on the Nasdaq this morning.
Copyright (c) 2019 CercleFinance.com. All rights reserved.